J
Jennifer Trofe
Researcher at University of Cincinnati
Publications - 77
Citations - 3387
Jennifer Trofe is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Transplantation & Immunosuppression. The author has an hindex of 29, co-authored 77 publications receiving 3248 citations. Previous affiliations of Jennifer Trofe include University of Pennsylvania & University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations
Hans H. Hirsch,Daniel C. Brennan,Cinthia B. Drachenberg,Fabrizio Ginevri,Jennifer Gordon,Ajit P. Limaye,Michael J. Mihatsch,Volker Nickeleit,Emilia Ramos,Parmjeet Randhawa,Ron Shapiro,Juerg Steiger,Manikkam Suthanthiran,Jennifer Trofe +13 more
TL;DR: It is recommended that all renal transplant recipients should be screened for BKV replication in the urine every three months during the first two years posttransplant; and if PVAN and concurrent acute rejection is diagnosed, antirejection treatment should be considered, coupled with subsequently reducing immunosuppression.
Journal ArticleDOI
Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study
C.C. Rogers,Rita R. Alloway,J. Wesley Alexander,Michael Cardi,Jennifer Trofe,Alexander A. Vinks,Alexander A. Vinks +6 more
TL;DR: The objective of this study was to describe the alterations in the PK of modern immunosuppressants and the GBS population.
Journal ArticleDOI
Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy
Yiping Chen,Jennifer Trofe,Jennifer Gordon,Renaud Du Pasquier,Prabir Roy-Chaudhury,Marcelo J. Kuroda,E. Steve Woodle,Kamel Khalili,Igor J. Koralnik +8 more
TL;DR: A high degree of epitope cross-recognition was present between BKV and corresponding JCV-specific CTLs, which indicates that the same population of cells is functionally effective against these two closely related viruses.
Journal ArticleDOI
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
Joseph F. Buell,Thomas G. Gross,Michael J. Hanaway,Jennifer Trofe,Prabir Roy-Chaudhury,M.R. First,E. S. Woodle +6 more
TL;DR: CNS involvement in transplant recipients with PTLD carries an ominous prognosis; however, isolated CNS involvement has a better prognosis than CNS plus extracranial involvement and radiation therapy alone provides the best results.
Journal Article
Donor transmitted malignancies.
Joseph F. Buell,T M. Beebe,Jennifer Trofe,Thomas G. Gross,Rita R. Alloway,Michael J. Hanaway,E. S. Woodle +6 more
TL;DR: This study examines the distribution of potential donor transmitted malignancies reported to the Israel Penn International Transplant Tumor Registry and seeks to identify specific factors associated with the risk of malignancy transmission from donor to recipient, in an effort to minimize future transmission of donor tumors to unwitting recipients.